Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Periodontology 2000|December 19, 2019
Periodontal therapeutics: Current host-modulation agents and future directionsLorne M Golub, Hsi-Ming Lee
Pharmacological Research|June 10, 2011
Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastaseYing Gu, Hsi-Ming Lee, Sanford R Simon, et al.
Frontiers in Clinical Diabetes and Healthcare|March 18, 2025
Diabetes, periodontal disease, and novel therapeutic approaches- host modulation therapyYing Gu, Lorne M Golub, Hsi-Ming Lee, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3Yu Liu, George Tortora, Maria E Ryan, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|September 27, 2005
Relationship between gelatinases and bone turnover in the healing bone defectRichard A Reinhardt, Hsi-ming Lee, Marian Schmid, et al.
FEMS Immunology and Medical Microbiology|November 14, 2009
Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdownYing Gu, Hsi-Ming Lee, Timo Sorsa, et al.
Journal of Experimental Pharmacology|April 7, 2022
SAGE: Novel Therapy to Reduce Inflammation in a Naturally Occurring-Dog Model of Periodontal DiseaseVeena Raja, Ying Gu, Hsi-Ming Lee, et al.
Annals of Medicine|October 6, 2005
Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclinesYing Gu, Hsi-Ming Lee, Lorne M Golub, et al.
Pageof 6